JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, C. D.
Right arrow Articles by Dubovsky, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, C. D.
Right arrow Articles by Dubovsky, E. V.
Journal of Nuclear Medicine Vol. 43 No. 6 762-766
© 2002 by Society of Nuclear Medicine


Clinical Investigations

A Bayesian Regression Model for Plasma Clearance

Charles D. Russell, MD, PhD1, Andrew T. Taylor, Jr, MD2 and Eva V. Dubovsky, MD, PhD1

1 University of Alabama Hospital and VA Medical Center, Birmingham, Alabama
2 Emory University, Atlanta, Georgia

Nonlinear Bayesian regression permits curve fitting to a group of subjects simultaneously rather than individually. We evaluated this approach for interpreting plasma clearance curves with the goal of reducing curve-fitting failures and dealing objectively with problem datasets that may arise in clinical settings. Methods: 99mTc-Diethylenetriaminepentaacetic acid plasma clearance curves from 79 subjects were analyzed. The data typically comprised 7–9 samples obtained from 5–10 to 180–240 min after injection. A 2-compartment model was fitted by Bayesian regression to yield compartmental hyperparameters V1, L21, and L12 corresponding to the volume of the compartment into which tracer was injected and the transfer rates from compartment 1 to compartment 2 and from compartment 2 to compartment 1, respectively. This also yielded a clearance estimate for each subject. Results: Estimated hyperparameters were V1 = 8.9 L, L21 = 0.026 min-1, and L12 = 0.040 min-1. Conventional methods led to fitting failures in 2 of the 79 subjects but there were no failures with the Bayesian method. The hyperparameters were used to calculate the glomerular filtration rate for each subject from a single plasma sample with a root-mean-square error of 7.3 mL/min, which was not significantly different from the widely used Christensen—Groth formula. Conclusion: Fewer fitting failures were encountered than with conventional methods, offering an objective means of dealing with problem data. This conceptually simple model can be used directly to calculate clearance from a single plasma sample. It requires only the 3 parameters described above, whereas the Christensen—Groth method requires 6 parameters.

Key Words: kidney function • glomerular filtration rate • renal clearance • plasma clearance




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Gref and K. Karp
GFR determination in adults with a single-sample iohexol plasma clearance method based on the mean sojourn time
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3166 - 3173.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. D. Russell
A Bayesian 3-Compartment Model for 99mTc-MAG3 Clearance
J. Nucl. Med., August 1, 2003; 44(8): 1357 - 1361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.